These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3163256)

  • 1. Prognostic significance of blood and marrow findings in acute myelogenous leukemia in remission. A Southeastern Cancer Study Group report.
    Vogler WR; Raney MR
    Cancer; 1988 Jun; 61(12):2481-6. PubMed ID: 3163256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.
    Stone RM; Maguire M; Goldberg MA; Antin JH; Rosenthal DS; Mayer RJ
    Blood; 1988 Mar; 71(3):690-6. PubMed ID: 3422828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow morphology during induction phase of therapy for acute myeloid leukemia (AML).
    Dick FR; Burns CP; Weiner GJ; Heckman KD
    Hematol Pathol; 1995; 9(2):95-106. PubMed ID: 7559259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
    Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
    Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognotic significance of pretreatment proliferative activity in adult acute leukemia.
    Hart JS; George SL; Frei E; Bodey GP; Nickerson RC; Freireich EJ
    Cancer; 1977 Apr; 39(4):1603-17. PubMed ID: 265746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group.
    Bertoli S; Bories P; Béné MC; Daliphard S; Lioure B; Pigneux A; Vey N; Delaunay J; Leymarie V; Luquet I; Blanchet O; Cornillet-Lefebvre P; Hunault M; Bouscary D; Fegueux N; Guardiola P; Dreyfus F; Harousseau JL; Cahn JY; Ifrah N; Récher C;
    Haematologica; 2014 Jan; 99(1):46-53. PubMed ID: 23975179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual Disease.
    Ollila TA; Olszewski AJ; Butera JN; Quesenberry MI; Quesenberry PJ; Reagan JL
    Clin Lymphoma Myeloma Leuk; 2018 Mar; 18(3):204-209. PubMed ID: 29433979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rebound peripheral blastosis with subsequent remission during remission induction in a patient with acute promyelocytic leukemia.
    Amato R; Kantarjian H; Walters R; Keating M
    Cancer; 1988 Feb; 61(4):650-3. PubMed ID: 3422175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prognostic significance of parameters of bone marrow blast cell proliferation in patients with acute leukemia].
    Kotel'nikov VM; Abakumov EM; Isaev VG; Morozova NG; Timkina EN
    Gematol Transfuziol; 1989 Nov; 34(11):14-8. PubMed ID: 2612858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of myelonecrosis after induction therapy in acute leukemia.
    Cassileth PA; Brooks JS
    Cancer; 1987 Nov; 60(10):2363-5. PubMed ID: 3311345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine bone marrow punctures during remission of acute myelogenous leukemia.
    Müller E; Sauter C
    Leukemia; 1992 May; 6(5):419. PubMed ID: 1593905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful hematopoietic reconstitution with granulocyte colony-stimulating factor in a patient with hypoplastic acute myelogenous leukemia.
    Lee M; Chubachi A; Niitsu H; Miura I; Yanagisawa M; Hirokawa M; Miura AB
    Intern Med; 1995 Jul; 34(7):692-4. PubMed ID: 7496088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual leukemic cell counts in the bone marrow at the end point of intensive induction therapy may be a prognostic factor for acute myeloblastic leukemia in adults.
    Fujisawa S; Maruta A; Motomura S; Fukawa H; Kanamori H; Ogawa K; Matsuzaki M; Miyashita H; Harano H; Murata T; Sakai R; Mohri H; Kodama F; Okubo T
    Leuk Lymphoma; 1998 Mar; 29(1-2):161-70. PubMed ID: 9638985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incidence and prognostic significance of Auer rods in children with acute myeloid leukemia in the studies AML-BFM-78 and -83].
    Vormoor J; Ritter J; Creutzig U; Schellong G
    Klin Padiatr; 1989; 201(4):227-32. PubMed ID: 2674529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of minimal residual disease in a patient having acute myelogenous leukemia with t(16;21)(p11;q22) treated by allogeneic bone marrow transplantation.
    Okoshi Y; Shimizu S; Kojima H; Obara N; Mukai HY; Komeno T; Hasegawa Y; Mori N; Nagasawa T
    Acta Haematol; 2001; 105(1):45-8. PubMed ID: 11340253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low platelet count reduces subsequent complete remission rate despite marrow with <5% blasts after AML induction therapy.
    Chen X; Newell LF; Xie H; Walter RB; Pagel JM; Sandhu VK; Becker PS; Hendrie PC; Abkowitz JL; Appelbaum FR; Estey EH
    Leukemia; 2015 Aug; 29(8):1779-80. PubMed ID: 25650090
    [No Abstract]   [Full Text] [Related]  

  • 17. Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia.
    Arellano M; Pakkala S; Langston A; Tighiouart M; Pan L; Chen Z; Heffner LT; Lonial S; Winton E; Khoury HJ
    Cancer; 2012 Nov; 118(21):5278-82. PubMed ID: 22517268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar organizer region counts predict complete remission, remission duration, and survival in adult acute myelogenous leukemia patients.
    Pich A; Chiusa L; Audisio E; Marmont F
    J Clin Oncol; 1998 Apr; 16(4):1512-8. PubMed ID: 9552060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukemia.
    Schultz KR; Massing B; Spinelli JJ; Gaynon PS; Wadsworth L
    Med Pediatr Oncol; 1997 Jul; 29(1):16-22. PubMed ID: 9142200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine bone marrow exam during first remission of acute myeloid leukemia.
    Estey E; Pierce S
    Blood; 1996 May; 87(9):3899-902. PubMed ID: 8611718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.